NCT04022447View on ClinicalTrials.gov

Dupilumab for Severe Asthma in a Real Life Setting

CompletedOBSERVATIONAL
Enrollment

86

Participants

Timeline

Start Date

August 10, 2018

Primary Completion Date

April 2, 2019

Study Completion Date

April 2, 2019

Conditions
Severe Asthma
Interventions
DRUG

Dupilumab

retrospective data collection

Trial Locations (1)

75018

Bichat-Claude Bernard University Hospital, Paris

All Listed Sponsors
lead

Assistance Publique - Hôpitaux de Paris

OTHER

NCT04022447 - Dupilumab for Severe Asthma in a Real Life Setting | Biotech Hunter | Biotech Hunter